News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Earnings
Baxter International, Inc. (BAX) Fourth Quarter 2014 Financial Results Conference Call 12/18/2014
Neogen Corporation (NEOG) Reports 26% Increase In Net Income 12/18/2014
Amgen (AMGN) Announces 30 Percent Increase In 2015 First Quarter Dividend 12/18/2014
BioReference Laboratories, Inc. (BRLI) Announces Quarterly And Yearly Record Revenues, Net Income And Patient Volumes 12/18/2014
NeuroDerm Ltd. (NDRM) Announces Third Quarter 2014 Financial Results And Provides A Corporate Update 12/18/2014
Eagle Pharmaceuticals (EGRX) Reports Fourth Quarter And Year End 2014 Financial Results 12/17/2014
Tenax Therapeutics (TENX) Announces Second Quarter Fiscal Year 2015 Financial Results 12/17/2014
Bristol-Myers Squibb Company (BMY) To Announce Results For Fourth Quarter, Full Year 2014 On January 27 12/17/2014
Bioanalytical Systems, Inc. (BASI) To Release Fourth Quarter Fiscal 2014 Results On Monday December 22, 2014; Conference Call & Webcast Set For 11:00 A.M. EST 12/17/2014
PAREXEL International (PRXL) Announces Date Of Second Quarter Fiscal Year 2015 Earnings Release And Conference Call 12/17/2014
Helix Biopharma (TSX:HBP) Announces Q1 Fiscal 2015 Results 12/16/2014
PDL BioPharma, Inc. (PDLI) Completes Regular Quarterly Dividend Payment 12/16/2014
Coherus Biosciences Reports Third Quarter 2014 Financial And Operating Results 12/16/2014
Bioanalytical Systems, Inc. (BASI) To Release Fourth Quarter Fiscal 2014 Results On Wednesday December 17, 2014; Conference Call & Webcast Set For 11:00 A.M. EST 12/15/2014
Polydex Pharmaceuticals (POLXF) Reports 3rd Quarter Financial Results 12/15/2014
Xenon Pharmaceuticals Inc. Reports Third Quarter 2014 Financial Results 12/15/2014
Origin Agritech Limited (SEED) To Announce Fiscal 2014 Annual Financial Results On January 8th, 2015 12/15/2014
Landauer (LDR)Announces Date And Time For Announcement Of Fiscal Fourth Quarter 2014 Results And Conference Call 12/15/2014
Abbott Laboratories (ABT) Announces Increase In Quarterly Dividend 12/12/2014
Peregrine Pharmaceuticals, Inc. (PPHM) Reports Second Quarter Fiscal Year 2015 Financial Results And Recent Developments 12/12/2014
Champions Oncology, Inc. (CSBR) Reports Results For The Second Quarter Ended October 31, 2014 12/12/2014
Peregrine Pharmaceuticals, Inc. (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 12/11/2014
Synergetics USA, Inc. (SURG) Reports First Quarter Of Fiscal Year 2015 Results 12/11/2014
BioReference Laboratories, Inc. (BRLI) Announces Earnings Date For Fourth Quarter And Year End For Fiscal Year 2014 12/11/2014
Tenax Therapeutics (TENX) To Provide Corporate Update And Discuss Second Quarter Fiscal Year 2015 Financial Results On December 17, 2014 12/11/2014
Abzena PLC Release: Interim Results For The Six Months Ended 30 September 2014 12/11/2014
Patterson Companies Declares Quarterly Dividend 12/10/2014
Scancell Holdings Plc Interim Results For The Six Months Ended 31 October 2014 12/10/2014
Bristol-Myers Squibb Company (BMY) Announces Dividend 12/10/2014
Enzo Biochem (ENZ) Reports Strong Fiscal First Quarter Results 12/10/2014
Dynasil Schedules Fiscal 2014 Financial Results Conference Call 12/10/2014
Champions Oncology, Inc. (CSBR) To Announce Second Quarter Financial Results On Friday, December 12 12/10/2014
Parnell Pharmaceuticals Holdings Announces Change In Fiscal Year-End 12/10/2014
OncoSec Medical Inc. Announces First Quarter Results For Fiscal Year End 2015 12/8/2014
AVANIR Pharmaceuticals (AVNR) Cancels Previously Scheduled Earnings Call 12/8/2014
Peregrine Pharmaceuticals, Inc. (PPHM) To Report Second Quarter Fiscal 2015 Financial Results After Market On December 10, 2014 12/5/2014
Coherus Biosciences To Host Earnings Conference Call On December 15 12/5/2014
Eagle Pharmaceuticals (EGRX) To Discuss 2014 Fourth Quarter And Year-End Financial Results On December 17, 2014 12/5/2014
Aceto Corporation Board Of Directors Declares Quarterly Cash Dividend 12/5/2014
Consort Medical Interim Results For The Six Months Ended 31 October 2014 12/4/2014
Auris Medical AG (EARS) Q3 2014 Earnings Release 12/3/2014
Nevro Corp Reports Third Quarter Financial Results 12/3/2014
Simulations Plus (SLP) Reports First Quarter FY2015 Preliminary Revenues 12/3/2014
GW Pharmaceuticals plc Reports 2014 Q4 And Full Year Financial Results 12/2/2014
Synergetics USA, Inc. (SURG) Announces Conference Call To Review First Quarter Of Fiscal Year 2015 Results 12/2/2014
AVANIR Pharmaceuticals (AVNR) Announces Date Of Fiscal 2014 Fourth Quarter Financial Results And Conference Call 12/2/2014
XTL Biopharmaceuticals Ltd. (XTLB) Provides Financial and Operational Update For the Third Quarter of 2014 12/1/2014
Antibe Therapeutics Inc. Reports Q2 2015 Interim Financial And Operating Results 12/1/2014
iCo Therapeutics Inc. Announces Third Quarter 2014 Financial Results And Corporate Update 12/1/2014
uniQure Announces Results For The Third Quarter Of 2014 12/1/2014
Auris Medical AG (EARS) To Announce Third Quarter 2014 Financial Results And Host Conference Call On Wednesday, December 3, 2014 12/1/2014
Pivotal Therapeutics Inc. Announces Third Quarter Accomplishments And Financial Results 12/1/2014
Analogic Corporation (ALOG) Announces Timing For First Quarter 2015 Earnings Conference Call And Webcast 11/26/2014
China Cord Blood Corporation Reports Financial Results For The Second Quarter And First Half Of Fiscal 2015 11/26/2014
Arrowhead Research Corporation (ARWR) Reports Fiscal 2014 Year End Financial Results 11/26/2014
Simulations Plus (SLP) Reports FY2014 And Fourth Quarter FY2014 Financial Results 11/26/2014
Proteon Therapeutics, Inc. (PRTO) Announces Third Quarter 2014 Financial Results 11/25/2014
Pall Corporation (PLL) Reports First Quarter Results 11/25/2014
GW Pharmaceuticals To Report Q4, Year-End 2014 Financial Results And Host Conference Call On 2 December, 2014 11/24/2014
Enanta Pharmaceuticals, Inc. Reports Financial Results For its Fiscal Fourth Quarter And Year Ended September 30, 2014 11/24/2014
Bio Blast Pharma Reports Third Quarter Financial Results 11/21/2014
Sientra, Inc. (SIEN) Reports Third Quarter 2014 Financial Results 11/20/2014
EDAP TMS S.A. (EDAP) Reports Continued Strong Growth In Third Quarter 2014 11/20/2014
Cellular Biomedicine Group (CBMG) Reports Third Quarter 2014 Financial Results And Provides Business Highlights 11/20/2014
Medivir AB (MVRBF): Interim Report, January – September 2014 11/20/2014
Taxus Cardium (CRXM) Reports On Third Quarter 2014 Results And Corporate Development Activities 11/20/2014
Arrowhead Research Corporation (ARWR) To Report Fiscal 2014 Fourth Quarter And Year End Financial Results 11/19/2014
Marina Biotech, Inc. (MRNA) Announces Third Quarter 2014 Financial Results 11/19/2014
Mallinckrodt plc Reports Fiscal 2014 Fourth Quarter And Fiscal 2014 Financial Results 11/19/2014
NeuroVive Pharmaceutical AB: Interim Report 1 Jan. 2014 To 30 Sep. 2014 11/19/2014
Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results For The Second Quarter Of Fiscal Year 2015 11/18/2014
ContraFect Corporation (CFRXU) Announces Third Quarter 2014 Results 11/18/2014
Skystar Bio-Pharmaceutical (CGPN) Reports Third Quarter Fiscal Year 2014 Financial Results 11/18/2014
Skystar Bio-Pharmaceutical (CGPN) To File Financial Results For Third Quarter Of Fiscal 2014 On Friday, November 14 11/18/2014
MYOS (MYOS) Reports 2014 Third Quarter Results And Provides Business Update 11/18/2014
Agilent Technologies Inc. (A) Reports Fourth-Quarter 2014 Results 11/18/2014
Cardio3 BioSciences Announces Q3 2014 Business Update 11/18/2014
Affimed Reports Financial Results For Third Quarter 2014 11/18/2014
Protea Biosciences, Inc. Announces 2014 Third Quarter Financial Results 11/18/2014
China Cord Blood Corporation To Report Second Quarter And First Half Of Fiscal 2015 Financial Results 11/18/2014
Omega Protein Corporation (OME) Announces Third Quarter 2014 Financial Results 11/18/2014
Palatin Technologies (PTN) Reports First Quarter Fiscal Year 2015 Results; Teleconference And Webcast To Be Held On November 18, 2014 11/18/2014
Fermentalg Q3 2014 Financial information 11/17/2014
Enanta Pharmaceuticals, Inc. To Host Conference Call To Discuss Financial Results For The Fiscal Fourth Quarter And Year Ended September 30, 2014 11/17/2014
Bio-Path Holdings, Inc. (BPTH) Reports Third Quarter 2014 Operational And Financial Results 11/17/2014
Enumeral Biomedical (ENUM) Reports Third Quarter 2014 Financial Results 11/17/2014
Corium International, Inc. Reports Fiscal Year-End 2014 Financial Results And Recent Corporate Developments 11/17/2014
Sevion Therapeutics Reports First Quarter 2015 Financial Results 11/17/2014
WuXi PharmaTech Co., Ltd. Reports Record Revenues, CapEx Spending 11/17/2014
ProSensa Holding N.V. (RNA) Announces 3rd Quarter 2014 Financial Results And Recent Corporate Developments 11/17/2014
Pressure BioSciences, Inc. (BBII) Reports Third Quarter 2014 Financial Results And Provides Business Update 11/17/2014
ULURU Inc. Reports Third Quarter 2014 Financial Results 11/17/2014
Sinovac Biotech Ltd. (SVA) Reports Unaudited Third Quarter Financial Results 11/17/2014
Anthera Pharmaceuticals, Inc. (ANTH) Reports 2014 Third Quarter Financial Results And Operational Update 11/17/2014
Nephros Inc. (NEP) Reports Third Quarter 2014 Financial Results And Announces Launch Of Rights Offering 11/17/2014
Inergetics, Inc.: 2014 Third Quarter Earnings Announcement 11/17/2014
ConvaTec Announces 2014 Third Quarter Earnings Call 11/17/2014
Alcobra (ADHD) Announces Third Quarter Financial Results And Provides Corporate Update 11/17/2014
Arno Therapeutics Reports Third Quarter 2014 Financial And Business Update 11/17/2014
VBI Reports Third Quarter 2014 Financial Results And Provides Update On CMV Vaccine Development 11/17/2014
Tengion Inc. Provides Clinical Update And Reports Third Quarter 2014 Financial Results And Cash Position 11/17/2014
Kite Pharma, Inc. (KITE) Reports Third Quarter 2014 Results 11/17/2014
AxoGen, Inc. (AXGN) Reports 58% Third Quarter Revenue Growth 11/14/2014
Nuo Therapeutics Reports Third Quarter 2014 Financial Results 11/14/2014
BIOQUAL Presents Financial Results For Fiscal Year 2014 And Declares Dividend 11/14/2014
Retrophin (RTRX) Reports Third Quarter 2014 Financial Results 11/14/2014
22nd Century Group, Inc. Reports Third Quarter 2014 Financial Results 11/14/2014
Stellar Biotechnologies, Inc. Reports Year-End 2014 Financial Results 11/14/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January – September 2014 11/14/2014
Catalent Reports First Quarter Fiscal Year 2015 Results 11/14/2014
ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) (QGLY) Reports Financial Results For The Three And Nine Months Ended September 30, 2014 11/14/2014
Titan Pharmaceuticals (TTP) Announces Third Quarter 2014 Financial Results 11/14/2014
ALK-Abello A/S Release: Nine-Month Interim Report (Q3) 2014 11/14/2014
Biostar Pharmaceuticals, Inc. (BSPM) Announces Third Quarter 2014 Financial Results 11/14/2014
Cord Blood America, Inc. Announces 2014 Third Quarter Financial Results 11/14/2014
Loxo Oncology (LOXO) Announces Third Quarter 2014 Financial Results 11/14/2014
Heat Biologics Reports 2014 Third Quarter Financial Results 11/14/2014
Emisphere Technologies, Inc. (EMIS) Announces Financial Results For The Third Quarter 2014 11/14/2014
Cerulean Pharma Inc. (CERU) Reports Third-Quarter 2014 Corporate Highlights And Financial Results 11/14/2014
FEI Company Announces Quarterly Cash Dividend Of $0.25 Per Share 11/14/2014
Elite Pharmaceuticals, Inc. (ELI) To Host Quarterly Business Update Call On Wednesday, November 19, 2014 11/14/2014
Nymox Pharmaceutical (NYMX) Reports Third Quarter 2014 Financial Results 11/14/2014
Ocera Therapeutics, Inc. (OCRX) Reports Third Quarter 2014 Financial Results 11/14/2014
Evoke Pharma, Inc. Reports Third Quarter 2014 Results 11/14/2014
Argos Therapeutics, Inc. (ARGS) Reports Third Quarter 2014 Financial Results And Operational Highlights 11/14/2014
Agile Therapeutics, Inc. Reports Third Quarter 2014 Financial Results 11/14/2014
Vital Therapies, Inc. (VTI) (VTL) Announces Third Quarter 2014 Financial Results And Provides A Corporate Update 11/14/2014
Flexion Therapeutics (FLXN) Reports Third-Quarter 2014 Financial Results 11/14/2014
CASI Pharmaceuticals  (ENMD) Reports Third Quarter 2014 Financial Results 11/14/2014
Synthetic Biologics, Inc. (SYN) Reports Third Quarter 2014 Financial Results And Operational Highlights 11/14/2014
China Pharma Holdings, Inc. (CPHI.OB) Reports Third Quarter 2014 Financial Results 11/14/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Reports Financial Results For Third Quarter And Nine Months Ended September 30, 2014 11/14/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Third Quarter 2014 Financial Results 11/14/2014
Palatin Technologies (PTN) To Report First Quarter Fiscal Year 2015 Results 11/14/2014
Calithera Biosciences, Inc. (CALA) Reports Financial Results For The Fiscal Quarter Ended September 30, 2014 11/14/2014
Cesca Therapeutics Reports First Quarter Fiscal 2015 Results 11/14/2014
CollabRx, Inc. Reports Second Quarter Fiscal Year 2015 Financial Results 11/14/2014
Capstone Therapeutics (CAPS) Will Provide An Operating Update And Announces Third Quarter 2014 Financial Results 11/14/2014
Dyadic International, Inc. Reports Q3 2014 Financial Results 11/14/2014
Pfenex Inc. (PFNX) Reports Third Quarter 2014 Results And Provides Business Update 11/14/2014
Celator Pharmaceuticals, Inc. Announces Business Update And Third Quarter 2014 Financial Results 11/14/2014
Intrexon Corporation Announces Third Quarter 2014 Financial Results 11/14/2014
Kindred Bio (KIN) Announces Third Quarter 2014 Financial Results 11/14/2014
Ruthigen Reports Fiscal Second Quarter 2015 Financial Results 11/14/2014
ImmuCell (ICCC) Announces Financial Results For Third Quarter Of 2014 11/13/2014
Eleven Biotherapeutics (EBIO) Reports Third Quarter 2014 Financial Results 11/13/2014
Sangui BioTech International Inc. (SGBI): Revenues Improved In The First Quarter Of The 2015 Financial Year 11/13/2014
Sophiris Bio Inc. (SPHS) Reports Third Quarter Financial Results 11/13/2014
La Jolla Pharmaceutical Company (LJPC) Announces Third Quarter And Year-To-Date 2014 Financial Results And Corporate Highlights 11/13/2014
RestorGenex Reports Third Quarter 2014 Financial Results 11/13/2014
Innocoll, Inc. (INNL) Announces Third Quarter 2014 Financial and Operating Results 11/13/2014
SCYNEXIS, Inc. (SCYX) Reports Third Quarter 2014 Financial Results 11/13/2014
Aastrom Biosciences, Inc. (ASTM) Reports Third-Quarter 2014 Financial Results 11/13/2014
Enzymotec Reports Third Quarter 2014 Unaudited Financial Results 11/13/2014
Marinus Pharmaceuticals (MRNS) Provides Business Update And Reports Third Quarter 2014 Financial Results 11/13/2014
VBL Therapeutics (VBLX) Announces Third Quarter 2014 Financial Results 11/13/2014
Rexahn Pharmaceuticals, Inc. (RNN) Reports Third Quarter 2014 Financial Results And Pipeline Update 11/13/2014
Ablynx (ABLYF) Announces Its Business Update For The First Nine Months Of 2014 11/13/2014
Vitae Pharmaceuticals, Inc. (VTAE) Reports Third Quarter 2014 Operating And Financial Results 11/13/2014
Dermira Reports Third Quarter 2014 Financial Results And Provides Corporate Update 11/13/2014
Otonomy, Inc. (OTIC) Reports Third Quarter 2014 Financial Results And Provides Corporate Update 11/13/2014
ReVance Therapeutics, Inc. (RVNC) Releases Third Quarter 2014 Results 11/13/2014
BrainStorm Cell Therapeutics Inc. Announces Financial Results For The Third Quarter Of 2014 And Provides Corporate Update 11/13/2014
Conatus Pharmaceuticals Inc. Reports Third Quarter 2014 Financial Results And Program Updates 11/13/2014
Amphastar Pharmaceuticals, Inc. (AMPH) Reports Revenues Of $59.7 Million For The Third Quarter Ended September 30, 2014 11/13/2014
OXiGENE (OXGN) Reports Third Quarter 2014 Financial Results 11/13/2014
CytoSorbents, Inc. Achieves First $1M In Quarterly Cytosorb Sales In Q3 2014 11/13/2014
RXi Pharmaceuticals (RXII) Reports Financial Results For The Third Quarter Of 2014 11/13/2014
WuXi PharmaTech Co., Ltd. Announces Third-Quarter 2014 Results 11/13/2014
Transition Therapeutics Inc. (TTH.TO) Announces First Quarter Fiscal 2015 Financial Results 11/13/2014
Imprimis Pharmaceuticals (immy) Reports On Third Quarter 2014 Financial Results And Provides Update On Business Developments 11/13/2014
Corbus Pharmaceuticals, Inc. Reports 2014 Third Quarter Results And Business Update 11/12/2014
MYOS (MYOS) To Announce Third Quarter 2014 Financial Results And Host Conference Call On November 14, 2014 11/12/2014
INSYS Therapeutics Reports Third Quarter 2014 Financial Results 11/12/2014
Aerie Pharmaceuticals, Inc. (AERI) Reports Third Quarter 2014 Financial Results And Provides Business And Product Development Update 11/12/2014
GlobeImmune, Inc. (GBIM) Announces Third Quarter 2014 Financial Results 11/12/2014
Veloxis Pharmaceuticals A/S (VELO) Announces Financial Results For The First Nine Months Of 2014 And Improves The Full Year Outlook 11/12/2014
Concert Pharmaceuticals, Inc. (CNCE) Reports Third Quarter 2014 Financial Results And Provides Update On CTP-354 Program 11/12/2014
Ocular Therapeutix, Inc. (OCUL) Reports Third Quarter 2014 Financial Results 11/12/2014
bluebird bio (BLUE) Reports Fiscal Third Quarter 2014 Financial Results 11/12/2014
Kamada Ltd. (KMDA) Announces Third Quarter 2014 Financial Results 11/12/2014
Dipexium Pharmaceuticals (DPRX) Reports Third Quarter 2014 Financial And Operational Results 11/12/2014
Avalanche Biotechnologies (AAVL) Reports Third Quarter 2014 Financial Results 11/12/2014
Aurinia (ISA.TO) Reports Third Quarter 2014 Financial Results 11/12/2014
Capricor Therapeutics, Inc. Reports Third Quarter 2014 Financial & Business Highlights 11/12/2014
Bioniche Life Sciences Inc. (BNC) Reports MCNA Update & First Quarter Results 11/12/2014
NovaBay Pharmaceuticals, Inc. (NBY) Reports Third Quarter 2014 Financial Results And A Clinical/Business Update 11/12/2014
GenVec Inc. (GNVC) Reports Third Quarter 2014 Financial Results 11/12/2014
Stemline Therapeutics, Inc. (STML) Reports Third Quarter 2014 Financial Results And Provides Corporate Update 11/12/2014
Immune Design Corporation (IMDZ) Reports Third Quarter 2014 Financial Results And Provides Corporate Update 11/12/2014
Cesca Therapeutics To Announce First Quarter Fiscal 2015 Results On November 13, 2014 11/12/2014
Atara Biotherapeutics (ATRA) Announces Third Quarter 2014 Operating Results 11/12/2014
Celladon Corporation Reports Third Quarter 2014 Financial Results And Recent Highlights 11/12/2014
Evotec AG (EVTG.F) Reports Results Of The First Nine Months Of 2014 11/12/2014
Supernus Pharmaceuticals (SUPN) Announces Third Quarter 2014 Results 11/12/2014
Cellectar Biosciences  (NVLT) Reports Third Quarter 2014 Financial Results And Recent Highlights 11/12/2014
Zafgen (ZFGN) Reports Third Quarter 2014 Financial Results 11/12/2014
Corium International, Inc. To Report Fiscal Year-End 2014 Financial Results On Monday, November 17, 2014 11/12/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Third Quarter 2014 Financial Results 11/12/2014
Fate Therapeutics (FATE) Reports Third Quarter 2014 Financial Results 11/12/2014



//-->